C3 glomerulopathy

Aude Servais1, Laure-Hélène Noël, Véronique Frémeaux-Bacchi

  • 1Department of a Nephrology, Service de Néphrologie adultes, Hôpital Necker, 149, rue de Sèvres, FR–75015 Paris, France. aude.servais@nck.aphp.fr

Insights

C3 glomerulopathy, a group of rare kidney diseases like dense deposit disease (DDD) and C3 glomerulonephritis (C3GN), involves complement alternative pathway (AP) dysregulation. Therapeutic inhibition of complement C3 and C5 offers future treatment prospects.

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Background:

  • C3 glomerulopathy is a classification of rare glomerulonephritis, including dense deposit disease (DDD) and C3 glomerulonephritis (C3GN).
  • Histological hallmarks include glomerular deposition of C3, primarily in the mesangium and along the glomerular basement membrane (GBM).
  • The complement alternative pathway (AP) plays a crucial role, with identified acquired or genetic abnormalities.

Purpose of the Study:

  • To review the classification, pathogenesis, clinical presentation, and therapeutic perspectives of C3 glomerulopathies.
  • To highlight the role of complement alternative pathway dysregulation and genetic factors.
  • To discuss the current understanding and future directions in managing these rare kidney diseases.

Main Methods:

  • Review of existing literature on C3 glomerulopathy, focusing on pathogenesis, genetics, clinical features, and treatment.
  • Analysis of histological findings, complement pathway abnormalities, and genetic associations.
  • Synthesis of information regarding clinical presentation, disease progression, and therapeutic strategies.

Main Results:

  • Low serum C3 with normal C4 is a common laboratory finding.
  • C3 nephritic factor (C3NeF) is implicated in acquired AP dysregulation, found in 80% of DDD and 45% of C3GN patients.
  • Mutations in complement regulatory proteins (CFH, CFI, C3) and genetic variants (SNPs in CFH, C3, CFHR5) are associated with disease development.

Conclusions:

  • C3 glomerulopathies are characterized by complement alternative pathway dysregulation, with varying genetic and acquired causes.
  • These diseases present with diverse renal manifestations and have a high risk of progression to end-stage renal disease (ESRD) and graft failure post-transplant.
  • Therapeutic strategies are evolving, with a focus on inhibiting complement components C3 and C5, and potential benefits from recombinant factor H or plasma exchange in specific deficiencies.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...